Pharmatech Taps R. Jerald Beers to Lead Business Development

  Pharmatech Taps R. Jerald Beers to Lead Business Development

Business Wire

HAYWARD, Calif. -- October 15, 2013

Pharmatech Associates, service provider to the pharmaceutical, biotech and
medical device industries, today announced the addition of veteran
biopharmaceutical executive R. Jerald Beers to lead business and commercial
development.

In a career spanning over 35 years, Beers has spearheaded business development
and commercialization activities for a number of companies important in the
growth and development of the pharmaceutical and biopharmaceutical industries.
Beers is joining Pharmatech at a time when demand for technical support is
increasing across a broad range of therapeutic areas for a consultancy with
fully integrated development experience that can provide assistance with
process qualification, facility operations, product design and
commercialization.

A co-founder of Itero Biopharmaceuticals, Inc., Beers brings to Pharmatech his
years of experience in biopharma and drug delivery product and molecule
partnering, along with business and commercial development, to complement
Pharmatech’s suite of product development services. Hepreviously held senior
executive level positions atGenentech, Inc.,Aradigm CorporationandQuestcor
Pharmaceuticals, Inc. on the West Coast, and spent nearly two decades in the
pharmaceutical industry at DuPont Pharmaceuticals, Inc.,American Hospital
Supply CorporationandG.D. Searle & Co. He holds a BA degree from Brown
University and a MBA degree from the Kellogg School of Management at
Northwestern University.

“Jerry Beers brings a wealth of business knowledge and industry expertise to
Pharmatech. His contributions and deep understanding will help us guide our
customers’ response to the challenges of product research, development and
commercialization as they meet product safety requirements effectively and
improve product manufacturing across the product lifecycle,” said Bikash
Chatterjee, President and CTO of Pharmatech Associates.

“What sets Pharmatech Associates apart is its ability to effectively partner
with each of its customers’ project teams, to deliver practical,
scientific-based solutions that align with global regulatory requirements and
drive improvements for better biopharmaceuticals and medical devices,” said
Jerry Beers.

About Pharmatech Associates

Pharmatech Associates was founded in 1995 by life sciences industry veterans
to address the need for science-based validation and regulatory compliance.
Over the past decade, the company’s service offerings and engagements have
extended to encompass the complete product lifecycle and include
manufacturing, regulatory, compliance and validation. From headquarters in the
San Francisco Bay Area, Pharmatech advises clients that range in size from
startups to large multi-national corporations on projects in Asia, Europe and
North America.

Contact:

SIPR for Pharmatech
Judy Curtis, + 1 650-274-1509
judy@sipr.com